I fear that ONT will struggle to get into routine diagnostics, the limitations surrounding its base calling accuracy is still being raised 10 years on. Institutions like the NHS in the UK cannot implement something like ONT whilst also requiring short read NGS to supplement its base calling limitation. Short read sequencing and other cheaper techniques like methylation arrays render this 3 in 1 approach via ONT 2nd best purely due to cost. For the NHS, cost saving is key, and ONT has been losing money ever since its inception - my fear is that it will never catch up. I really hope I am wrong, ONT is a great piece of kit - I would love to see it in the NHS for routine diagnostics. I think we could solve some of our mystery families fairly quickly with ONT.
I fear that ONT will struggle to get into routine diagnostics, the limitations surrounding its base calling accuracy is still being raised 10 years on. Institutions like the NHS in the UK cannot implement something like ONT whilst also requiring short read NGS to supplement its base calling limitation. Short read sequencing and other cheaper techniques like methylation arrays render this 3 in 1 approach via ONT 2nd best purely due to cost. For the NHS, cost saving is key, and ONT has been losing money ever since its inception - my fear is that it will never catch up. I really hope I am wrong, ONT is a great piece of kit - I would love to see it in the NHS for routine diagnostics. I think we could solve some of our mystery families fairly quickly with ONT.